News
Peptide research, protocols, and industry insights from our team.
Thymalin and NAD+ for Immunometabolic Longevity: Can Thymic Peptides Enhance Cellular NAD+ Pools to Counter GLP-1-Related Immune Aging?
Thymalin and NAD+ intersect in immunometabolic aging, but evidence is thin. This article maps what is known, what is untested, and where GLP-1 drugs
Read articleGHK-Cu and Vesugen for Vascular Rejuvenation: Can Copper Peptide and Bioregulator Synergy Support Endothelial Health Amid GLP-1 Skin Changes?
GLP-1 agonists cause rapid weight loss, but skin quality suffers. Can GHK-Cu and Vesugen synergize to support vascular health? ...
Read moreThymalin and GLP-1 Agonists: Immunosenescence Risks in AUD Trials
GLP-1 agonists show promise for alcohol use disorder in VA trials, but immunosenescence risks loom. Thymalin, a thymic peptide,...
Read moreGHK-Cu and MOTS-c Synergy: Skin, Mitochondria, and the FDA Panel's Peptide Shift
The FDA panel's peptide endorsement could expand access to GHK-Cu and MOTS-c, two compounds targeting skin aging and mitochondr...
Read moreGHK-Cu and Epitalon Synergy: Telomere Support Meets Skin Rejuvenation Amid the FDA Panel Vote on Peptide Access
GHK-Cu and Epitalon target different aging mechanisms: skin matrix remodeling and telomere support. We examine the evidence for...
Read moreThymalin and Epitalon After the FDA Panel Vote: Can Compounded Peptides Bridge the Gap?
The FDA panel vote against MDMA therapy raises questions for compounded peptides like Thymalin and Epitalon. Can they meet the ...
Read moreThymalin and Immune Rejuvenation: Can Thymic Peptides Reverse Immunosenescence?
Thymalin, a synthetic thymic peptide, is studied for its potential to reverse immunosenescence. Evidence is mostly preclinical,...
Read more